Healthcare

Gilead vaccine

Healthcare – Growth At An Attractive Price

Mathieu Racheter, Strategy Research, Julius Baer | Global healthcare remains our most preferred defensive sector due to attractive valuations in combination with solid growth perspectives. We see a number of structural tailwinds including demographics, big data, and increased demand in emerging markets, all of which should continue to drive above-average sales and earnings growth going forward. Healthcare remains our most preferred defensive sector due to attractive growth perspectives and undemanding…